wellmedr Reviews
The lowest long-run compounded GLP-1 price we found - semaglutide from $49/mo on a 12-month plan
Last updated: Sep 27, 2026
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
wellmedr has the lowest long-run price on our list: $49/month semaglutide locked for 12 months, and $89/month tirzepatide, with no price increase as your dose rises. Its customer reviews are also the strongest we could verify.
It ranks fifth rather than higher because that headline price depends on a 12-month commitment - a big decision when many people change medication or stop within the first year - and because month-to-month pricing is less competitive than embody's. If you are sure you want a year of treatment, wellmedr is excellent value; if you want to keep your options open, choose a no-commitment program.
Compounded GLP-1s are not FDA-approved, results vary, and a licensed clinician decides whether treatment is right for you. This review is general information, not medical advice.
wellmedr is a broad telehealth platform - it also covers TRT, NAD+, hair and sexual health - with a GLP-1 program priced to win on long-term cost. Its headline rate is compounded semaglutide at $49/month, but that price is locked in only on a 12-month plan; month-to-month is advertised at around $88/month.
Compounded tirzepatide is $89/month, shipped every 4 weeks, and both are the same price at every dose. Board-certified clinicians review your intake, with video or messaging follow-up, and it is available in all 50 states.
It also has the strongest Trustpilot score of the providers we rank that publish one. As with every compounded program, these medications are not FDA-approved.
This review covers what wellmedr costs, what the 12-month plan means for you, and who it suits.
Key Features
- Compounded semaglutide $49/month on a 12-month plan (rate locked)
- Compounded tirzepatide $89/month, shipped every 4 weeks
- Same price at every dose
- Board-certified clinicians; async intake plus video or messaging
- GLP-1 + NAD+/B12 microdose option; brand-name shelf
- Available in all 50 states; ships in 3-5 business days
Treatment Options
- Compounded semaglutide (same price at every dose)
- Compounded tirzepatide (shipped every 4 weeks)
- GLP-1 + NAD+/B12 microdose option
- Brand-name Ozempic and Zepbound (self-pay)
- Other programs: TRT, NAD+, hair and sexual health
Pricing
Semaglutide - 12-month plan
12-month plan, rate locked (month-to-month ~$88/mo)Compounded semaglutide
- Same price at every dose
- Board-certified clinicians
- All 50 states
Tirzepatide
Shipped every 4 weeksCompounded tirzepatide
- Same price at every dose
- Video or messaging follow-up
- Ships in 3-5 business days
Brand-name shelf
Self-pay pricesOzempic / Zepbound
- Ozempic $1,399/mo
- Zepbound $1,599/mo
wellmedr's compounded semaglutide is $49/month on its 12-month plan, with the rate locked for the year; month-to-month is higher, advertised at around $88/month. Compounded tirzepatide is $89/month, shipped every 4 weeks.
Prices are the same at every dose. Brand-name medication is available at self-pay prices: Ozempic $1,399/month and Zepbound $1,599/month.
The $49 rate is the lowest long-run price on our list, but it assumes you are comfortable committing to 12 months - check the plan terms, including cancellation, before you sign up. Compounded GLP-1s are not FDA-approved.
How wellmedr Works
- 1Step 1
Online intake
Complete an asynchronous health intake and choose your plan - 12-month for the lowest rate, or month-to-month.
- 2Step 2
Clinician review
A board-certified clinician reviews your history, with video or messaging if needed, and decides whether a GLP-1 is appropriate.
- 3Step 3
Delivery every 4 weeks
If prescribed, medication ships in 3-5 business days, then arrives on a regular 4-week cycle.
Pros
- Lowest long-run price we found - semaglutide $49/month on the 12-month plan
- Tirzepatide at $89/month, and prices do not rise with your dose
- Strongest published Trustpilot score on our list (4.6 / 5 from 1,919 reviews)
- Board-certified clinicians, available in all 50 states
Cons
- The $49 price requires a 12-month commitment; month-to-month is around $88/month
- Compounded medication is not FDA-approved or FDA-reviewed for safety, effectiveness or quality
- Slower shipping than embody or trimrx - 3-5 business days
- A broad multi-category platform rather than a weight-loss specialist
Who It's Best For
- People confident they will stay on a GLP-1 for a year and want the lowest total cost
- Anyone who wants tirzepatide at a low flat price
- Those in states other providers do not serve
- Skip it if you want flexibility to stop in a month or two - embody is cheaper month-to-month
Final Verdict
wellmedr has the lowest long-run price on our list: $49/month semaglutide locked for 12 months, and $89/month tirzepatide, with no price increase as your dose rises. Its customer reviews are also the strongest we could verify.
It ranks fifth rather than higher because that headline price depends on a 12-month commitment - a big decision when many people change medication or stop within the first year - and because month-to-month pricing is less competitive than embody's. If you are sure you want a year of treatment, wellmedr is excellent value; if you want to keep your options open, choose a no-commitment program.
Compounded GLP-1s are not FDA-approved, results vary, and a licensed clinician decides whether treatment is right for you. This review is general information, not medical advice.
wellmedr Review: FAQs
Is wellmedr legit?
wellmedr is a broad telehealth platform - it also covers TRT, NAD+, hair and sexual health - with a GLP-1 program priced to win on long-term cost. Its headline rate is compounded semaglutide at $49/month, but that price is locked in only on a 12-month plan; month-to-month is advertised at around $88/month. Compounded tirzepatide is $89/month, shipped every 4 weeks, and both are the same price at every dose. Board-certified clinicians review your intake, with video or messaging follow-up, and it is available in all 50 states. It also has the strongest Trustpilot score of the providers we rank that publish one. As with every compounded program, these medications are not FDA-approved. This review covers what wellmedr costs, what the 12-month plan means for you, and who it suits.
How much does wellmedr cost?
wellmedr's compounded semaglutide is $49/month on its 12-month plan, with the rate locked for the year; month-to-month is higher, advertised at around $88/month. Compounded tirzepatide is $89/month, shipped every 4 weeks. Prices are the same at every dose. Brand-name medication is available at self-pay prices: Ozempic $1,399/month and Zepbound $1,599/month. The $49 rate is the lowest long-run price on our list, but it assumes you are comfortable committing to 12 months - check the plan terms, including cancellation, before you sign up. Compounded GLP-1s are not FDA-approved.
What treatments does wellmedr offer?
wellmedr offers Compounded semaglutide (same price at every dose), Compounded tirzepatide (shipped every 4 weeks), GLP-1 + NAD+/B12 microdose option, Brand-name Ozempic and Zepbound (self-pay), Other programs: TRT, NAD+, hair and sexual health.
Who is wellmedr best for?
wellmedr is best for People confident they will stay on a GLP-1 for a year and want the lowest total cost; Anyone who wants tirzepatide at a low flat price; Those in states other providers do not serve; Skip it if you want flexibility to stop in a month or two - embody is cheaper month-to-month.
Is wellmedr worth it?
wellmedr has the lowest long-run price on our list: $49/month semaglutide locked for 12 months, and $89/month tirzepatide, with no price increase as your dose rises. Its customer reviews are also the strongest we could verify. It ranks fifth rather than higher because that headline price depends on a 12-month commitment - a big decision when many people change medication or stop within the first year - and because month-to-month pricing is less competitive than embody's. If you are sure you want a year of treatment, wellmedr is excellent value; if you want to keep your options open, choose a no-commitment program. Compounded GLP-1s are not FDA-approved, results vary, and a licensed clinician decides whether treatment is right for you. This review is general information, not medical advice.
Related
Sources & methodology
We built this review of wellmedr from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- wellmedr - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 2.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize - U.S. Food & Drug Administration
- 3.Wegovy (semaglutide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 4.Zepbound (tirzepatide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 5.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) - Wilding et al. - New England Journal of Medicine, 2021;384:989-1002
- 6.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) - Jastreboff et al. - New England Journal of Medicine, 2022;387:205-216
- 7.Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) - Aronne et al. - New England Journal of Medicine, 2025
- 8.Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension - Wilding et al. - Diabetes, Obesity and Metabolism, 2022
- 9.Prescription Medications to Treat Overweight & Obesity - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.